newsfilter
← Latest News
PR Newswire·

Oramed Signs Definitive Deal with Medicox to Commercialize Oral Insulin in South Korea

Medicox to Distribute Oramed's Oral Insulin in South Korea, if approvedOramed to Receive Up to $18 Million in Developmental MilestonesOramed to Receive up to 15% Royalties on Gross SalesLarge Market Potential: 1 in 7